Postoperative Tizanidine Use in Pelvic Reconstructive Surgery: A Pilot Study
Recruiting
Phase 2
Interventional Study
Post Operative
Post Operative Analgesia
Urogynecologic Surgery
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 89
- Sex
- Female
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 186 (estimated)
- Sponsor
- Hartford Hospital · Other
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to evaluate whether adding tizanidine to the standard postoperative pain regimen improves recovery after pelvic reconstructive surgery in adult women. The main questions it aims to answer are:
Does postoperative tizanidine improve patient-reported recovery 4-6 weeks after surgery? Does tizanidine reduce postoperative pain, opioid use, constipation, and healthcar…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* female, age ≥18 and ≤89 years old
* any race/ethnicity
* English and/or Spanish fluency
* undergoing apical suspension:
* sacrocolpopexy (laparoscopic or robotic)
* uterosacral ligament suspension (vaginal, laparoscopic, or robotic)
* sacrospinous ligament …
Contacts